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People may reach the upper limits of the human life span at least partly because they have maintained more appropriate 
immune function, avoiding changes to immunity termed “immunosenescence.” Exceptionally long-lived people may be 
enriched for genes that contribute to their longevity, some of which may bear on immune function. Centenarian offspring 
would be expected to inherit some of these, which might be reflected in their resistance to immunosenescence, and con-
tribute to their potential longevity. We have tested this hypothesis by comparing centenarian offspring with age-matched 
controls. We report differences in the numbers and proportions of both CD4+ and CD8+ early- and late-differentiated T 
cells, as well as potentially senescent CD8+ T cells, suggesting that the adaptive T-cell arm of the immune system is more 
“youthful” in centenarian offspring than controls. This might reflect a superior ability to mount effective responses against 
newly encountered antigens and thus contribute to better protection against infection and to greater longevity.
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InCREASInG age is accompanied by a decreased ability of the immune system to protect against new antigenic 
challenges or to control chronic infections, and increased 
immune dysregulation also reflected in chronically elevated 
signs of systemic inflammation. These age-associated 
changes over the life span, loosely termed immunosenes-
cence and inflamm-aging, are associated with a decline in 
the normal functioning of the different components of the 
immune system. Hence, there is a reduction in responsive-
ness as well as a functional deregulation of immune effec-
tor cells and an alteration of the cytokine and chemokine 
environment in the elderly population (1). T cells play a 
major role in defense against infection and in the secretion 
of pro- and anti-inflammatory factors, but in the elderly 
people, the balance of T-cell phenotypes in the peripheral 
blood is markedly different from that seen in most young 
people, in a manner most commonly interpreted as indicat-
ing impaired functionality in the former. This is thought 
to contribute to poorer vaccine responses, increasing inci-
dence of infection, and reactivation of latent viruses in old 
people (2). Cross-sectional studies indicate that the most 
noticeable differences in young and old people lie in the 
frequencies and absolute numbers of naïve and different 
differentiation stages of memory T cells. These data are 
generally interpreted as a dynamic process of decreasing 
frequency of naïve T cells and increasing frequency of 
memory T cells with age, due to conversion of naïve cells to 
memory cells after antigen contact, although in the absence 
of longitudinal studies, this assumption cannot be formally 
proven. However, limited longitudinal studies in the very 
elderly people have shown that an accumulation of late-
stage differentiated CD8+ T cells resulting in an inverted 
CD4:CD8 ratio and poor T-cell proliferative responses to 
mitogens formed the central plank of the “immune risk pro-
file” (IRP), which did indeed predict mortality at 2-, 4-, and 
6-year follow-up (3). It is of note that the number of naïve 
CD8+ T cells was not part of the IRP. Intriguingly, cyto-
megalovirus (CMV) infection, however, was part of the IRP 
and has been postulated to be the main driver of the accu-
mulation of late-stage differentiated CD8+ T cells in the at-
risk group. It is now clear that CMV itself influences T-cell 
phenotype distribution, independently of age, but becoming 
more marked in elderly populations with a higher percent-
age of CMV-infected individuals (4–6). In some studies, 
CMV infection is closely related to both a reduction of 
CD8+ naïve T cells and increase of CD8+ late-differentiated 
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effector memory (6), whereas in other studies, the loss of 
naïve cells was reported to be age dependent but not CMV 
dependent (7).
Because essentially no older individuals can escape from 
all age-related diseases, such as atherosclerosis, osteopo-
rosis, sarcopenia, or insulin resistance, defining the elderly 
individuals as healthy is challenging. For this reason, the 
term “delayed aging” may better describe a group of peo-
ple, such as centenarians, who have presumed genetic and 
functional advantages resulting in a lesser risk of devel-
oping major age-related diseases and, as a consequence, 
survive longer in a good condition (8). Studies of families 
with exceptionally long-lived participants have suggested 
that genetic background may contribute a very signifi-
cant advantage in terms of longevity compared with the 
general population (9). Older individuals in such families 
also exhibit more “youthful” immune profiles in that their 
immune signatures are more similar to those of younger 
individuals than to age-matched (AM) controls. When 
infected with CMV, they appear resistant to the alterations 
in T-cell phenotype distribution caused by this virus in the 
general population (10). Centenarian offspring (CO) may 
be a special population of older individuals that, like their 
centenarian parent(s), could also have genetic and func-
tional advantages that predispose them to healthy aging and 
longer survival (11–13). Data on B cells have shown that 
CO appear more similar to young donors than AM sporadic 
controls (14) and do not show the typical naïve–memory 
shift observed in the elderly people (15). Recently, we also 
demonstrated that the IgM memory B-cell pool present in 
CO is not reduced to the same extent as in their AM con-
trols and remains more similar to that observed in young 
people (16). Here, we asked whether the T-cell compart-
ment of CO is also resistant to the imputed age-associ-
ated changes observed in AM controls having no history 
of familial longevity. We report higher numbers and per-
centages of CD28+CD27+CD45RA+CD45RO− naïve cells 
within the CD4+ as well as CD8+ subsets in CO compared 
with the general elderly population, whereas there were 
fewer CD28−CD27−CD45RA+CD45RO+ late-differentiated 
CD8+ T cells in CO. Moreover, CO had lower numbers and 
percentages of CD8+CD57+ putatively senescent T cells 
compared with the general population of elderly people. 
These data on CO T-cell distribution imply that cellular 
immune capacity is likely to be better preserved in CO than 
AM random controls and could provide a survival advan-




A total of 21 Sicilian CO have been identified and inves-
tigated (age range: 70.1 ± 8.3; 10 men and 11 women), with 
at least one centenarian parent (>99  years). Fifteen AM 
controls (age range: 69.1 ± 9.7; 7 men and 8 women), 10 
old (O) participants (age range: 86.4 ± 3.8; 5 men and 5 
women), and 12 young participants (age range: 28.5 ± 1.9; 
7 men and 5 women) from Sicily were also included in the 
study. All participants were in good health at the moment of 
the recruitment, as revealed by blood tests (complete blood 
cell count, erythrocytes, C-reactive protein, liver function 
tests, iron, proteins). The controls were collected from the 
same population as the patient cohort. Characteristics of 
these individuals and their clinical history are summarized 
in Table 1.
The University Hospital Ethics Committee approved the 
study, and written informed consent was obtained from all 
participants according to Italian law.
All participants were tested for CMV serostatus by 
ELISA using CMV-IgG-ELISA PKS assays (Genesis 
Diagnostics, United Kingdom). All the elderly participants 
were positive for CMV antibody (CO, AM, and O), whereas 
none of the young participants were infected.
Whole blood was collected by venepuncture in vacu-
tainer tubes containing ethylenediaminetetraacetic acid, at 
the same time of day for all participants. Peripheral blood 
Table 1. Characteristics and Clinical History of Individuals Studied
Young People Centenarian Offspring Age Matched Old People
Participants 12 21 15 10
Gender 7 men, 5 women 10 men, 11 women 7 men, 8 women 5 men, 5 women
Age, mean (SD) 28.5 (1.9) 70.1 (8.3) 69.1 (9.7) 86.4 (3.8)
Prevalence of disease, n (%)
 Myocardial infarction 0 (0.0) 0 (0.0) 2(13.3) 2 (20)
 Stroke 0 (0.0) 1 (4.8) 2 (13.3) 1 (10)
 Hypertension 0 (0.0) 3 (14.3) 5 (33.3) 2 (20)
 Cancer 0 (0.0) 1 (4.8) 2 (13.3) 2 (20)
 Rheumatoid arthritis 0 (0.0) 0 (0.0) 1 (6.7) 1 (10)
Level of education, n (%)
 Only primary education 2 (13.3) 10 (100)
 Secondary education 19 (90.5) 11 (73.3)
 Higher education 12 (100) 2 (9.5) 2 (13.3)
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mononuclear cells were separated using a Ficoll/Hypaque 
gradient (Cedarlane Laboratories Limited, Ontario, Canada) 
and viably cryopreserved according to standard protocols.
Flow Cytometry
To analyze T-lymphocyte subsets, peripheral blood 
mononuclear cells were adjusted to 1 × 106/mL and stained 
with antibodies. Direct immunofluorescence was per-
formed with anti-CD3-AlexaFluor700, CD8-PercP, CD28-
PercP-Cy5.5 (Becton Dickinson, Heidelberg, Germany), 
CD4-Qdot705 (Invitrogen, Karlsruhe, Germany), CD27-
Qdot605 (Invitrogen), CD45RO-eFluor650 (eBiosci-
ence, San Diego, CA), CD45RA-PacificBlue (BioLegend, 
Biozol, Eching, Germany), and CD57-FITC (Immunotools, 
Friesoythe, Germany).
Cell viability was determined with RedVid (Invitrogen). 
All staining steps were performed in PFEA buffer (phos-
phate-buffered saline, 2% fetal calf serum, 2 mM ethylen-
ediaminetetraacetic acid, and 0.01% na azide). Blocking 
of nonspecific binding sites was accomplished using 
human immunoglobulin GAMUnEX (Bayer, Leverkusen, 
Germany) or mouse serum (Caltag/Invitrogen, Karlsruhe, 
Germany). For each experiment, cells or mouse/rat κ-chain 
Comp Beads (Becton Dickinson) were stained with the 
corresponding fluorochrome-labeled antibodies and incu-
bated for 20 minutes at 4°C in the dark. Human unstained 
cells were used as negative controls. After washing with 
PFEA, the cells or beads were resuspended and measured 
using an LSR-II flow cytometer and the acquisition soft-
ware FACSDiva (Becton Dickinson). Data were analyzed 
using FlowJo software (Tree Star, Ashland, OR). For data 
analysis, dead cells (RedVid-positive) were excluded. CD3+ 
living cells were gated within the side scatter/forward scat-
ter (SSC/FSC) lymphocyte gate. Further analysis was per-
formed using CD3+CD4+ and CD3+CD8+ gated populations.
Statistics
All statistical analyses were performed with Graph-Pad 
Prism 4.0 using the Mann–Whitney nonparametric U test 
to compare two independent groups. Differences were con-
sidered significant with a p value ≤ .05. Significant differ-
ences are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001 . 
Significant differences between young (Y) versus old (O) 
participants are not indicated because the purpose of this 
study is to compare CO with sporadic AM controls, not 
with the young participants, where differences are clearly 
significant.
Results
T-Cell Phenotype Distribution in CO, AM Controls, and 
Old and Young Participants
To determine the T-cell immune profile of CO compared 
with the general population, we first investigated the distri-
bution of CD3+, CD4+, and CD8+ T cells. Characteristics of 
individuals studied and their clinical history are summarized 
in Table 1. Young people tended to have a higher percentage 
of CD4+ and fewer CD8+ T lymphocytes than the elderly 
people and, as a consequence, their average CD4:CD8 ratio 
was greater (Table 2). There was a slight but nonsignificant 
increase in the mean percentage of CD4+ T cells within the 
CD3+ T-cell population in CO as a group compared with the 
AM controls. A similar slight trend is also visible for CD8+ 
T cells, but in this case, CO had a lower percentage com-
pared with AM controls. These slight shifts also affected the 
CD4:CD8 ratio. As a consequence, CO show a higher ratio 
compared with their AM controls (Table 2). The CD4:CD8 
ratio cutoff for inclusion in the IRP is less than or equal to 1; 
the data presented here indicate that, as expected, no young 
controls fell into this group, whereas 3/10 old people (30%) 
had a CD4:CD8 ratio of less than or equal to 1 (Figure 1). 
In this respect, CO and AM controls differed little (p > .05), 
with 5/21 CO (23.8%) and 4/15 AM (26.6%) falling into the 
IRP group by this criterion (Figure 1).
Costimulatory Molecules on CD4+ and CD8+ T Cells
next, the expression of the costimulatory molecules 
CD27 and CD28 on CD4+ and CD8+ cells was analyzed. 
These two markers are useful to identify the stage of differ-
entiation of T cells because they are expressed in the early 
stage and not in the latest stage of differentiation with CD28 
downregulated before CD27 on CD8+ T cells and vice versa 
in CD4+ cells (17,18). We therefore compared T-cell dif-
ferentiation status between the four groups analyzed. 
The percentage of early differentiated CD4+CD27+ cells 
(Figure 2A) in young people is significantly higher than in 
any of the elderly groups (CO, AM, O). nonetheless, within 
the elderly population, CO have on average a significantly 
greater percentage of CD4+CD27+ cells than their AM 
controls (or the old group). The same result was observed 
Table 2. Lymphocyte Subpopulations in Young People, Centenarian Offspring (CO), Age-Matched (AM) Controls, and Old People
Lymphocyte Subpopulations
Young People 
(age 28.5 ± 1.9), mean ± SD
CO (age 70.1 ± 8.3),  
mean ± SD
AM (age 69.1 ± 9.7), 
mean ± SD
Old People 
(age 86.4 ± 3.8), mean ± SD
CD3+ 73.4 ± 16.7 71.5 ± 8.7 72.2 ± 7.2 73.9 ± 8.1
CD4+ 58.2 ± 11.2 55.5 ± 18.9 47.1 ± 14.3 48.8 ± 15.6
CD8+ 23.3 ± 6.6 24.2 ± 9.9 30.3 ± 11.6 31.6 ± 8.4
CD4:CD8 ratio 2.6 ± 0.9 2.4 ± 1.9 1.9 ± 1.6 1.8 ± 1
 at Sistem
a Bibliotecario - U







498 PELLICANÒ ET AL.
analyzing the absolute cell number (data not shown). For 
CD4+CD28+ cells, we observed a similar pattern, with a 
higher expression of CD28 in young people compared with 
the older group; CO again had more CD4+CD28+ cells than 
their AM controls, although in this case, the difference did 
not reach significance (p = .06, data not shown).
Within the CD8 subset, again, significantly higher 
percentages of CD27+ and CD28+ cells were observed in 
young people compared with any of the elderly groups 
(CO, AM, O). Also here, there was a significant difference 
between CO and AM controls for the expression of CD27 
as percentages (Figure 2B) and absolute numbers (data not 
shown). A trend toward a higher percentage of CD28+ cells 
was observed (p = .1, data not shown).
Naïve and Memory T Cells Within the CD4+ and the 
CD8+ Populations
naïve and memory T cells can be identified by analyzing 
the expression of two isoforms of the protein phosphatase 
CD45 (CD45RA and CD45RO), with naïve cells more likely 
to express CD45RA and memory cells CD45RO. Although 
assessing the expression of CD45RA and CD45RO provides 
some information on T-cell differentiation status (Figures 
3B and 4B), they are not by themselves sufficient to distin-
guish between naïve and memory cells as CD45RA is also 
reexpressed by late-differentiated memory cells (19). For 
this reason, we have analyzed the expression of CD45RA 
and CD45RO together with CD27 and CD28 to identify 
T-cell phenotypes in detail. As previously reported, we con-
sidered the phenotype CD27+CD28+CD45RA+CD45RO− as 
the naïve T cells and CD27−CD28−CD45RA+CD45RO+ as 
the late-differentiated cells (20).
We confirmed here that naïve CD4+ (CD27+CD28+CD4
5RA+CD45RO−) cells are more frequent in young people 
than in any of the groups of elderly people (Figure  3A). 
The percentage of naïve cells in AM controls (and old 
participants) is again significantly lower than in CO 
(p = .005, Figure 3A and B). The same result was observed 
analyzing the absolute cell counts of naïve CD4+ (p = .002, 
Figure  3C). Differences were more noticeable when we 
analyzed naïve and late memory CD8+ T cells in detail. 
There were fewer naïve CD8+ T cells in all elderly groups 
(Figure 4A and B), but CO again had a significantly higher 
proportion of naïve CD8+CD27+CD28+CD45RA+CD45RO− 
cells than their AM controls (p =  .005). Also in this case, 
the absolute cell number of naïve CD8+ cells is significant 
higher in CO compared with AM (p = .002, Figure  4C). 
Reciprocally, a higher percentage of late-differentiated 
CD4+ cells (CD27−CD28−CD45RA+CD45RO+) in the older 
groups is less evident in CO although this difference did not 
reach significance, neither as percentage (p = .1, Figure 5A) 
or absolute number of cells (p = .1, Figure 5B).
Figure 1. CD4:CD8 ratio in young (Y) controls, centenarian offspring (CO), 
age-matched (AM) controls, and old (O) people. Peripheral blood mononuclear 
cells were stained with CD3, CD4, and CD8 antibodies. The CD4:CD8 ratio 
was calculated within CD3+ cells. Bars represent medians. Significant differ-
ences valuated by Mann–Whitney nonparametric U testing are indicated by *p 
≤ .05, **p ≤ .01, ***p ≤ .001. The horizontal dotted line indicates a CD4:CD8 
ratio of ≤1.
Figure 2. Costimulatory molecule CD27 expression in young (Y) controls, centenarian offspring (CO), age-matched (AM) controls, and old (O) people. Peripheral 
blood mononuclear cells of 12 young controls (age range: 28.5 ± 1.9; 7 men and 5 women), 21 CO (age range: 70.1 ± 8.3; 10 men and 11 women), 15 AM controls 
(age range: 69.1 ± 9; 7 men and 8 women), and 10 old (O) participants (age range: 86.4 ± 3.8; 5 men and 5 women) were stained for CD3, CD4, CD8, and CD27. The 
percentages of CD27+ (early differentiated) lymphocytes are shown for CD4+ (A) and CD8+ T cells (B). Bars represent medians. Significant differences evaluated by 
Mann–Whitney nonparametric U testing are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001.
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Along the same lines, the percentage of late-differenti-
ated (CD8+CD27−CD28−CD45RA+CD45RO+) cells was 
significantly lower in CO compared with both AM controls 
and old people both as percentage (p = .003, Figure 5C) and 
absolute number of cells (p = .002, Figure 5D).
Potentially Senescent CD4+ and CD8+ T Cells
Previous studies have suggested that lifelong antigenic 
exposure may lead to increased frequencies of end stage–
differentiated CD8+ T cells that have often been designated 
“senescent” in the literature. These cells are characterized 
inter alia by the expression of the inhibitory receptor CD57 
(21). Therefore, we analyzed the percentage of CD57+ cells, 
finding that the older groups had a significantly higher per-
centage of CD57+ cells than young people. Although for 
CD4+ cells, there were no differences between CO and AM 
controls or older people (p > .05, data not shown), percent-
ages of CD8+CD57+ cells were significantly lower in CO 
than in AM controls and older people (p = .0005, Figure 6), 
suggesting that fewer “senescent” T cells are accumulating 
in CO. The same trend was present when we analyzed abso-
lute cell numbers.
Discussion
Compromised and dysregulated immunity is commonly 
assumed to be a cause of the increased susceptibility and sen-
sitivity to infectious disease and poor response to vaccina-
tion in old people. The immune system, which is constantly 
challenged by external and internal agents, undergoes dra-
matic changes with age. These cumulative changes include 
those resulting from decreased thymic output following 
puberty, alterations in lymphocyte population dynamics in 
late life, and reduced intracellular signaling within those 
cells (22,23). Alterations in T-cell immunity imputed to 
occur dynamically with aging are reflected in altered num-
bers and proportions of T-cell phenotypes. One of the conse-
quences of the developmentally programed involution of the 
thymus in humans is the rapidly declining output of naïve T 
lymphocytes after puberty. In aged humans, after the age of 
70, naïve CD4+ T cells have declined to such an extent that 
Figure 3. CD4+ naïve cells. Peripheral blood mononuclear cells from young (Y) controls, centenarian offspring (CO), age-matched (AM) controls, and old (O) 
people as in Figure 2 were stained with CD3, CD4, CD28, CD27, CD45RA, and CD45RO to identify naïve cells. Percentages (A) and absolute cell counts (C) of 
CD28+CD27+CD45RA+CD45RO− naïve cells of 12 young controls, 21 CO, 15 AM controls, and 10 old participants. Bars represent medians. (B) Representative dot 
plots of naïve CD4+ T-cell distribution in a young control (upper left), in a CO (upper right), in an AM (lower left), and in an old participant (lower right). Significant 
differences are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001.
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their capacity to help B cells to provide efficient humoral 
responses may be compromized (24–26). As a result of 
thymic involution, the peripheral T-cell repertoire is not 
replenished, correlating with the impaired immune response 
that characterizes old individuals (27). Thus, the elderly peo-
ple have low percentages of naïve T cells that display numer-
ous functional defects and are associated with mortality, 
primarily from infectious diseases. The mirror image of this 
situation is an increased representation of late-differentiated 
memory T cells that occurs as a consequence of a lifetime’s 
exposure to microbial and other agents.
Similar changes in the CD8+ subpopulation take place even 
earlier in life than in CD4+ T cells (28,29). In particular, in 
the CD8 compartment, late-differentiated CD45RA+CD28− 
T cells accumulate with age and their increased frequencies 
inversely correlate with vaccine responses (30–32). Thus, it 
is clear that T cells become significantly less able to engage 
in effective immune responses and to become functional 
memory cells as we age, as also seen in mice (33). Many 
of these CD8+ T cells with a late-differentiated phenotype 
are likely to be CMV specific and their accumulation is 
much less marked in older CMV-seronegative individuals 
(6,8–10). Indeed, it was demonstrated that repeated expo-
sure to antigens directly affects the T-cell arm and patho-
gens and thus directly contribute to immunosenescence 
(29,34). Chronic CMV infection has an enormous impact 
on all the changes observed in elderly people. It seems that 
not only chronological age alone but also persistent CMV 
infection “accelerates” what is commonly interpreted as 
immune aging, materially influencing the distribution of 
T-cell phenotypes in the peripheral blood of old individuals 
(1,10,35–37). In general, CD4+ as well as CD8+ T cells are 
affected by chronic CMV response, although the magnitude 
of the effect is greater for CD8+ T cells (38,39), and other 
herpes viruses probably contribute little (40).
Recently, we have demonstrated that CMV-seropositive 
individuals from families enriched for longevity have 
higher percentages of naïve T cells and lower percentages 
of CD45RA-reexpressing and late-differentiated effector 
memory T cells than the general AM population. These peo-
ple also have lower levels of the proinflammatory marker 
C-reactive protein compared with AM CMV-seropositive 
Figure 4. CD8 naïve cells. Peripheral blood mononuclear cells from young (Y) controls, centenarian offspring (CO), age-matched (AM) controls, and old (O) 
people as in Figure 2 were stained with CD3, CD8, CD28, CD27, CD45RA, and CD45RO to identify naïve cells. Percentages (A) and absolute cell count (C) of 
CD28+CD27+CD45RA+CD45RO− naïve cells of 12 young controls, 21 CO, 15 AM controls, and 10 old participants. Bars represent medians. (B) Representative dot 
plots of naïve CD8+ T-cell distribution in a young control (upper left), in a CO (upper right), in an AM (lower left), and in an old participant (lower right). Significant 
differences are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001.
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controls, suggesting a lower proinflammatory status despite 
CMV infection (less “inflamm-aging”). The analysis of 
immune signatures of offspring genetically enriched for 
longevity has revealed marked differences compared with 
the general elderly population that might better result in 
protection not only from infectious disease but also from 
cardiovascular morbidity and other inflammatory diseases 
such as diabetes (10). Such family studies facilitate the 
identification of genes that are also expected to affect on 
immune function in old age.
In the present study, we performed a phenotypic analysis 
of the T-cell arm of adaptive immunity in a group of Sicilian 
CO, a special population of elderly people presumed to be 
genetically advantaged for longevity, and who may share 
Figure 5. CD4+ and CD8+ late-differentiated cells. Peripheral blood mononuclear cells from young (Y) controls, centenarian offspring (CO), age-matched (AM) 
controls, and old (O) people as in Figure 2. The percentages and absolute cell count of late differentiated CD28−CD27−CD45RA+CD45RO+ within CD4+ cells (A 
and B) and within CD8+ cells (C and D) are shown. Significant differences between the four groups analyzed evaluated by Mann–Whitney nonparametric U testing 
are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001.
Figure 6. CD8+CD57+ “senescent” cells. Peripheral blood mononuclear cells from young (Y) controls, centenarian offspring (CO), age-matched (AM) controls, 
and old (O) people as in Figure 2 were stained with CD3, CD8, and CD57. Percentages (A) and absolute number (B) of CD8+CD57+ cells in 12 young controls, 21 
CO, 15 AM controls, and 10 old people are shown. Bars represent medians. Differences between the four groups analyzed evaluated by Mann–Whitney nonparamet-
ric U testing are indicated by *p ≤ .05, **p ≤ .01, ***p ≤ .001.
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some of the same characteristics as members of long-lived 
families. Here, we have analyzed very rare people with at 
least one centenarian parent (100–107  years of age) and 
compared these results with those of a previous article on 
familial longevity (10) in which the individuals studied 
ranged from 40 to 70 years of age with at least one parent 
having at least one sibling that lived to be more than 90. Thus, 
the present study specifically sought phenotypic similarities 
in cohorts derived in a very different manner (offspring of 
sporadic vs familial longevity). To emphasize the likely 
genetic contribution, rather than the environmental, we 
selected the present cohort from a southern European 
population, which will have experienced very different 
exposures (food, weather conditions, culture, pathogens, 
etc.). Also given the fact that these populations are likely 
to be genetically different, we sought to identify prevalent-
shared immune signatures despite all these possible 
confounding differences in the population. The results 
indicate some striking similarities between the two different 
cohorts, emphasizing the potential biological relevance to 
longevity of these findings under quite different conditions.
We have recently demonstrated that offspring of a cen-
tenarian parent also have a “younger” B-cell as well as 
T-cell profile that could help them resist infection (14,16). 
Here, we have analyzed the T-cell immune profile of CO 
(age range: 70.1 ± 8.3) compared with equally elderly 
people without a familial history of longevity (age range: 
69.1 ± 9.7), and also with unrelated very elderly individuals 
(age range: 86.4 ± 3.8). All were evaluated for CMV status 
and found to be uniformly positive. Thus, any differences 
seen between CO and other elderly people cannot be solely 
due to CMV infection, whereas differences between any 
of the elderly groups and the young groups, who were all 
CMV-negative, are mostly likely caused by CMV.
The distribution of the CD4+ and CD8+ subsets within 
CD3+ T cells was analyzed in terms of the CD4:CD8 ratio 
because this is one of the immunological parameters included 
in the IRP in the Swedish OCTO/nOnA longitudinal 
studies (41–43). As there are few studies of the IRP in 
different populations, it remains of interest to explore its 
presence and relevance in non-Swedish cohorts. We found 
that CO had a higher CD4:CD8 ratio compared with their 
AM controls, again appearing more similar to the CMV-
negative young people in this respect, despite being CMV-
positive. As previously demonstrated for the B-cell arm of 
the immune system (14,15), the T-cell arm is probably better 
preserved in CO than in sporadic AM controls. This could be 
a consequence of an increased thymic output, due to slower 
involution or, alternatively, to less primarily CMV-driven 
peripheral post thymic expansion that causes a significant 
contraction of the peripheral T-cell receptor repertoire in 
most elderly people (44). This remains to be investigated, 
for example, by assessing T cell receptor (TREC) levels.
Analysis of CD27 and CD28 expression, which defines 
an early stage of T-cell differentiation, confirmed higher 
percentages in young people compared with the elderly 
people. Comparison of the four groups revealed that the 
percentages of CD4+CD27+ cell subsets were significantly 
higher in the presumed genetically advantaged CO group 
compared with their AM controls, with CO again looking 
more similar to the young groups. For CD28 expression 
on CD4+ and CD8+ cells, the differences between CO and 
controls remained trends but did not reach statistical sig-
nificance. next, we evaluated naïve T cells within the CD4+ 
and CD8+ populations. Our recent detailed classification 
defined them as CD27+CD28+CD45RA+CD45RO− (20). As 
expected, CD8+ naïve T cells were more frequent in young 
donors than in the general elderly population, but here we 
also saw fewer CD4+ naïve cells, not always seen in every 
published study or in our own previous studies on other 
populations. This may be due to population effects and the 
relatively small numbers of donors tested here, or to true 
population differences in Sicilians. Using these phenotyp-
ing panels, we had previously observed fewer CD4+ naïve 
cells in Western populations only under pathological con-
ditions (notably, Alzheimer’s disease) (20,45). However, 
we have observed a more pronounced effect on CD4+ 
naïve cells in a non-European population where people are 
considered old at a much earlier chronological age than 
in the West and might well be expected to have a higher 
pathogen load (46). The patterns observed in the Sicilian 
elderly population seem to fall midway between those of 
the commonly studied northern European and U.S. popula-
tions, and the rural Pakistani population studied by Alam 
and colleagues.
The presence of fewer naïve cells is commonly mir-
rored by accumulations of memory cells, which have 
a more restricted repertoire for recognizing patho-
gens to which the individual was previously exposed. 
Consistent with the higher level of naïve T cells in CO, 
percentages of late-differentiated CD8+ memory T cells 
(CD27−CD28−CD45RA+CD45RO+) were significantly 
lower in CO than in the general elderly population and 
were in fact similar to those in the young group. Although 
the differences between young (CMV−) and elderly 
(CMV+) groups can mostly be attributed to the expansion 
of CMV-specific clones, the lowest percentage of memory 
T cells observed in CO (who were also all CMV+) may be 
due to more efficient maintenance of immune surveillance 
against this potentially dangerous pathogen. Consistent 
with this, the analysis of putatively senescent CD57-
expressing cells within CD8+ T lymphocytes, that previous 
studies have reported as increased in elderly people when 
compared with young people (21), also indicated that CO 
showed a phenotype more similar to the CMV-negative 
young people than the CMV-positive AM controls and 
very old people. In this respect, CO do appear very simi-
lar to the offspring of long-lived parents in familial lon-
gevity studies (10). Seeking shared genetic parameters in 
these two disparate populations might therefore assist in 
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identifying the nature of the genes possibly contributing 
to extended human longevity.
Taken together, data reported here suggest that CO do 
not show the typical naïve/memory trend observed in the 
random elderly people, despite all being CMV-positive. The 
adaptive immune system (both B- and T-cell arms) appears 
“better conserved” in the offspring of centenarians (ie, more 
like that seen in younger CMV-negative people), and less 
susceptible to the major effects that CMV infection has on 
the general population. This may contribute to their abil-
ity to resist typical age-related diseases and imbue them 
with an increased probability to reach the extreme limits of 
human life as their centenarian parent did. The similarity 
between these results and those from the Leiden Longevity 
Study of familial longevity suggests the presence of longev-
ity-promoting genes shared between quite different popula-
tions conveying resistance to the effects of CMV infection 
on immune signatures commonly believed to be mark del-
eterious immune function.
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